NASDAQ: HLVX - HilleVax, Inc.

Yield per half year: +1.59%
Dividend yield: 0.00%
Sector: Healthcare

Share chart HilleVax, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About HilleVax, Inc.

HilleVax, Inc., биофармацевтическая компания клинической стадии, занимается разработкой и коммерциализацией новых вакцин. Он разрабатывает HIL-214, вакцину-кандидат на основе вирусоподобных частиц для профилактики острого гастроэнтерита средней и тяжелой степени, вызванного норовирусной инфекцией. Штаб-квартира компании находится в Бостоне, штат Массачусетс.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2022-04-29
ISIN US43157M1027
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.hillevax.com
Цена ао 1.92
Change price per day: 0% (1.92)
Change price per week: +3.78% (1.85)
Change price per month: +14.29% (1.68)
Change price per 3 month: +10.34% (1.74)
Change price per half year: +1.59% (1.89)
Change price per year: -87.28% (15.1)
Change price per 3 year: -87.73% (15.65)
Change price per year to date: -1.03% (1.94)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 0.6586 10
P/E 0 0
EV/EBITDA 0.1816 10
Total: 5

Efficiency

Title Value Grade
ROA, % -54.84 0
ROE, % -70.13 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.1579 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 7294.81 10
Yield EPS, % 2204.68 10
Total: 8
More

Institutions Volume Share, %
Frazier Life Sciences Management, L.P. 9781472 19.68
Deerfield Management Company, L.P. (Series C) 4004231 8.06
Deep Track Capital, LP 2900000 5.83
VR Adviser, LLC 2075000 4.17
Franklin Resources, Inc. 1846396 3.72
Carlyle Group Inc. 1838486 3.7
Blackrock Inc. 1775937 3.57
Vanguard Group Inc 1464840 2.95
T. Rowe Price Investment Management, Inc. 1453790 2.93
Catalys Pacific, LLC 1308974 2.63

ETFShare, %Profitability for 1 year, %Dividends, %
iShares Morningstar Small-Cap ETF 0.00081 391.25 1.60498
0391.251.6



Head Job title Payment Year of birth
Dr. Robert M. Hershberg M.D., Ph.D. Co-Founder, President, CEO & Chairman of the Board 1.02M 1962 (63 years)
Dr. Anju Chatterji Ph.D. Chief Technology Officer N/A
Mr. Paul S. Bavier J.D. General Counsel, Secretary & Chief Administrative Officer N/A 1972 (53 years)
Ms. Astrid Borkowski M.D., Ph.D. Chief Medical Officer N/A 1970 (55 years)
Mr. Shane A. Maltbie CFO & Treasurer N/A 1982 (43 years)
Mr. Ozzie Berger Senior Vice President of Regulatory Affairs N/A
Dr. Aditya Kohli Ph.D. Co-Founder, Chief Business Officer & Director 782.44k 1988 (37 years)
Mr. Sean McLoughlin Chief Operating Officer N/A 1972 (53 years)

Address: United States, Boston. MA, 75 State Street - open in Google maps, open in Yandex maps
Website: https://www.hillevax.com